Log in to save to my catalogue

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68923726

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

About this item

Full title

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

Journal title

Current pharmaceutical design, 2006-09, Vol.12 (27), p.3467-3484

Language

English

Formats

Publication information

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

Erectile dysfunction (ED) has multifactor pathogenesis, with neurological, vascular, endocrinological and psychogenic components described. However, about 50-85% of ED population report the presence of one or more comorbidities i.e. hypertension, diabetes, cardiovascular disease, dyslipidemia which all impair endothelial function and, erection is a...

Alternative Titles

Full title

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68923726

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68923726

Other Identifiers

ISSN

1381-6128

E-ISSN

1873-4286

DOI

10.2174/138161206778343046

How to access this item